Cargando…

Exosome: A New Player in Translational Nanomedicine

Summary: Exosomes are extracellular vesicles released by the vast majority of cell types both in vivo and ex vivo, upon the fusion of multivesicular bodies (MVBs) with the cellular plasma membrane. Two main functions have been attributed to exosomes: their capacity to transport proteins, lipids and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aheget, Houssam, Tristán-Manzano, María, Mazini, Loubna, Cortijo-Gutierrez, Marina, Galindo-Moreno, Pablo, Herrera, Concha, Martin, Francisco, Marchal, Juan Antonio, Benabdellah, Karim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463834/ https://www.ncbi.nlm.nih.gov/pubmed/32722531 http://dx.doi.org/10.3390/jcm9082380

Ejemplares similares

Exosomes: Their Role in Pathogenesis, Diagnosis and Treatment of Diseases
por: Aheget, Houssam, et al.
Publicado: (2020)

Genome‐edited adult stem cells: Next‐generation advanced therapy medicinal products
por: Benabdellah, Karim, et al.
Publicado: (2020)

Improved Functionality of Integration-Deficient Lentiviral Vectors (IDLVs) by the Inclusion of IS(2) Protein Docks
por: Cortijo-Gutiérrez, Marina, et al.
Publicado: (2021)

Artificial exosomes for translational nanomedicine
por: Li, Yong-Jiang, et al.
Publicado: (2021)

Using Gene Editing Approaches to Fine-Tune the Immune System
por: Pavlovic, Kristina, et al.
Publicado: (2020)

Externally-Controlled Systems for Immunotherapy: From Bench to Bedside
por: Tristán-Manzano, María, et al.
Publicado: (2020)

Physiological lentiviral vectors for the generation of improved CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2022)

Physiological lentiviral vectors for the generation of improved CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2022)

Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2023)

Failure of ALL recognition by CAR T cells: a review of CD 19-negative relapses after anti-CD 19 CAR-T treatment in B-ALL
por: Aparicio-Pérez, Clara, et al.
Publicado: (2023)

Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma
por: Maldonado-Pérez, Noelia, et al.
Publicado: (2022)

Exosomes and Micro-RNAs in Aging Process
por: Hamdan, Yousra, et al.
Publicado: (2021)

Exosomes contribution in COVID-19 patients’ treatment
por: Mazini, Loubna, et al.
Publicado: (2021)

Challenges in nanomedicine clinical translation
por: Metselaar, Josbert M., et al.
Publicado: (2020)

Polymalic acid for translational nanomedicine
por: Huang, Xing, et al.
Publicado: (2022)

The Role of Optical Imaging in Translational Nanomedicine
por: Hesemans, Evelien, et al.
Publicado: (2022)

Promoting the bench-to-bedside translation of nanomedicines
por: Zhang, Ning
Publicado: (2023)

Exosomes in Gliomas: Biogenesis, Isolation, and Preliminary Applications in Nanomedicine
por: Romano, Eugenia, et al.
Publicado: (2020)

Tango of dual nanoparticles: Interplays between exosomes and nanomedicine
por: Wang, Yabin, et al.
Publicado: (2021)

Nanomedicine: Application Areas and Development Prospects
por: Boulaiz, Houria, et al.
Publicado: (2011)

Editorial: Translating nanomedicines for anti-cancer treatment
por: Siram, Karthik, et al.
Publicado: (2023)

Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform
por: Xu, Xiao, et al.
Publicado: (2023)

The Potential of Zebrafish as a Model Organism for Improving the Translation of Genetic Anticancer Nanomedicines
por: C, Gutiérrez-Lovera, et al.
Publicado: (2017)

Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation
por: Burnouf, Thierry, et al.
Publicado: (2019)

Current hurdles to the translation of nanomedicines from bench to the clinic
por: Đorđević, Snežana, et al.
Publicado: (2021)

Bioimaging guided pharmaceutical evaluations of nanomedicines for clinical translations
por: Tuguntaev, Ruslan G., et al.
Publicado: (2022)

Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges
por: Cano, Amanda, et al.
Publicado: (2023)

The IS2 Element Improves Transcription Efficiency of Integration-Deficient Lentiviral Vector Episomes
por: Sánchez-Hernández, Sabina, et al.
Publicado: (2018)

Exosomes: New players in cancer
por: Guo, Wei, et al.
Publicado: (2017)

Cancer nanomedicine
por: Bhatia, Sangeeta N., et al.
Publicado: (2022)

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
por: Hua, Susan, et al.
Publicado: (2018)

Towards principled design of cancer nanomedicine to accelerate clinical translation
por: Souri, Mohammad, et al.
Publicado: (2022)

Current approaches of nanomedicines in the market and various stage of clinical translation
por: Shan, Xiaoting, et al.
Publicado: (2022)

Post-Translational Modifications of Exosomal Proteins
por: Moreno-Gonzalo, Olga, et al.
Publicado: (2014)

Development of Cellular Models to Study Efficiency and Safety of Gene Edition by Homologous Directed Recombination Using the CRISPR/Cas9 System
por: Sánchez-Hernández, Sabina, et al.
Publicado: (2020)

Virus-modified exosomes for targeted RNA delivery; A new approach in nanomedicine()
por: Koppers-Lalic, Danijela, et al.
Publicado: (2013)

Mesenchymal Stem Cell–Derived Exosomes: A Promising Biological Tool in Nanomedicine
por: Wei, Wumei, et al.
Publicado: (2021)

Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers
por: Acebes-Fernández, Vanessa, et al.
Publicado: (2020)

Exosomes as Pleiotropic Players in Pancreatic Cancer
por: De Lellis, Laura, et al.
Publicado: (2021)

Anticancer Nanotherapeutics in Clinical Trials: The Work behind Clinical Translation of Nanomedicine
por: Parodi, Alessandro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ntfecv5nv6033o8p0gmfbe8amm